Abstract
Aims
To investigate the possible correlation between platelet aggregation and the severity of diabetic retinopathy using the light-scattering method.
Methods
Using a light-scattering platelet aggregometer, we measured spontaneous platelet aggregation in 86 diabetics with retinopathy of varying severity and 30 healthy volunteers (controls). Platelet aggregates were classified as small, medium, and large according to their light intensity; patients were grouped based on the severity of retinopathy. In each patient group, we recorded for 10 min the total light intensities emitted by each aggregate size in the area under the curve (AUC). Then, we compared the AUC of each level of retinopathy severity with the controls and determined the correlation between the AUC of each aggregate size and each severity level.
Results
Of the 86 diabetics, 22 had no apparent retinopathy (NAR), 13 had mild nonproliferative diabetic retinopathy (NPDR), 17 had moderate NPDR, 12 had severe NPDR, and 22 had proliferative diabetic retinopathy (PDR). While the NAR group manifested significantly more small aggregates than the controls (20.5×106 versus 8.3×106 a.u., p=0.024), none of the other groups showed a significant increase in aggregates of any size. In the AUC of large aggregates, there was a weak-positive correlation with the severity of retinopathy (r=0.255, p=0.018); in the AUC of small and medium aggregates, there was no correlation.
Conclusion
Although we did not find a significant correlation between platelet aggregation and the severity of diabetic retinopathy, our pilot study did detect some tendencies. Further studies on larger populations are underway to determine whether these tendencies are real.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agardh CD, Agardh E, Bauer B (1987) Platelet aggregation in type I diabetics with and without proliferative retinopathy. Acta Ophthalmol 65:358–362
Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927–929
Born GVR (1970) Observations on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol 209:487–511
ETDRS Investigators (1992) Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 268:1292–1300
Fukuda K, Ozaki Y, Satoh K, Kume S, Tawata M, Onaya T, Sakurada K, Seto M, Sasaki Y (1997) Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes 46:488–493
Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y (1999) Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 93:271–278
Gear AR, Lambrecht JK (1981) Reduction in single platelets during primary and secondary aggregation. Thromb Haemost 45:298 (letter)
Gensini GF, Abbate R, Favilla S, Neri Serneri GG (1979) Changes of platelet function and blood clotting in diabetes mellitus. Thromb Haemost 42:983–993
Halushka PV, Rogers RC, Loadholdt CB, Colwell JA (1981) Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97:87–96
Haque SF, Matsubayashi H, Izumi S, Sugi T, Arai T, Kondo A, Makino T (2001) Sex difference in platelet aggregation detected by new aggregometry using light scattering. Endocr J 48:33–41
Ishii H, Umeda F, Nawata H (1992) Platelet function in diabetes mellitus. Diabetes/Metab Rev 8:53–66
Iwase E, Tawata M, Aida K, Ozaki Y, Kume S, Satoh K, Qi R, Onaya T (1998) A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism 47:699–705
Kitek A, Breddin K (1980) Optical density variations and microscopic observations in the evaluation of platelet shape change and microaggregate formation. Thromb Haemost 44:154–158
Matsuno H, Kozawa O, Nagashima S, Kanamaru M, Uematsu T (1999) Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates. Br J Pharmacol 127:1129–1134
Miyamoto S, Kawano H, Sakamoto T, Soejima H, Kajiwara I, Shimomura H, Kojima S, Hokamaki J, Sugiyama S, Hirai N, Yoshimura M, Ozaki Y, Ogawa H (2003) Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease. Thromb Haemost 89:681–686
Nakamura T, Ariyoshi H, Kambayashi J, Ikeda M, Kawasaki T, Sakon M, Monden M (1997) Effect of low concentration of epinephrine on human platelet aggregation analyzed by particle counting method and confocal microscopy. J Lab Clin Med 130:262–270
Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S (1994) Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 218:284–294
Sagel J, ColwellJA, Crook L, Laimins M (1975) Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 82:733–738
Sakamoto T, Ogawa H, Kawano H, Hirai N, Miyamoto S, Takazoe K, Soejima H, Kugiyama K, Yoshimura M, Yasue H (2000) Rapid change of platelet aggregability in acute hyperglycemia. Thromb Haemost 83:475–479
Spencer BK III, Ehtisham M (1999) Will blocking the platelet save the diabetic? Circulation 100:2466–2468
The DAMAD Study Group (1989) Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy: a multicenter randomized controlled clinical trial. Diabetes 38:491–498
The TIMAD Study Group (1990) Ticlopidine treatment reduces the progression of non-proliferative diabetic retinopathy. Arch Ophthalmol 108:1577–1583
Tohgi H, Takahashi H, Watanabe K, Kuki H, Shirasawa Y (1996) Development of large platelet aggregates from small aggregates as determined by laser-light scattering: effects of aggregant concentration and antiplatelet medication. Thromb Haemost 75:838–843
Tomida Y, Iino S, Nishikawa M, Hidaka H (1998) A new system to detect native microaggregates of platelets in vivo, with a novel platelet aggregometer employing laser light scattering. Thromb Res 92:221–228
Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL (2001) Platelet dysfunction in type 2 diabetes. Diabetes Care 24:1476–1485
Wilkinson CP, Ferris FL III, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT, Global Diabetic Retinopathy Project Group (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682
Yamamoto T, Egawa Y, Shirasawa T (1995) A laser light scattering in situ system for counting aggregates in blood platelet aggregation. Meas Sci Technol 6:174–180
Yamamoto T, Kamei M, Yokoi N, Yasuhara T, Tei M, Kinoshita S (2004) Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering. Am J Ophthalmol 138:809–817
Acknowledgements
The authors thank Mr. Tatsuo Terashima for his valuable contribution to the statistical analysis of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no commercial or proprietary interest in any of the companies, products, or methods described in this article.
Rights and permissions
About this article
Cite this article
Yamamoto, T., Kamei, M., Yokoi, N. et al. Platelet aggregates in various stages of diabetic retinopathy: evaluation using the particle-counting light-scattering method. Graefe's Arch Clin Exp Ophthalmol 243, 665–670 (2005). https://doi.org/10.1007/s00417-004-1101-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-004-1101-x